High prevalence of hepatitis B virus genotype C/C1 in the Minangkabau ethnic group in Indonesia by Marlinang D Siburian et al.
Siburian et al. Virology Journal 2013, 10:27
http://www.virologyj.com/content/10/1/27RESEARCH Open AccessHigh prevalence of hepatitis B virus genotype C/C1
in the Minangkabau ethnic group in Indonesia
Marlinang D Siburian1, Andi Utama1*, Rama Dhenni1, Arnelis2, Ismail Fanany1, Mariana DB Intan1, Tri S Kurniasih1,
Febi Andriani1, Szeifoul Afadlal1, Erlys B Julianto3, Widyarman S Rasman3, Nasrul Zubir2
and George Mathew1Abstract
Background: The Minangkabau is one of the major ethnic groups in Indonesia. Previous studies with a limited
number of samples have shown a different prevalence of HBV/C in the Minangkabau compared to the Indonesian
population in general. The aim of this study was to assess the HBV genotype distribution pattern and the
prevalence of pre-S, T1753V and A1762T/G1764A mutations among the Minangkabau HBV carriers. The samples
were collected from Padang, West Sumatera and from western Java. Mixed primers for specific genotypes were
used to determine the HBV genotype. Pre-S or S genes were amplified, sequenced and aligned with reference
sequences from GenBank to derive a phylogenetic tree for subgenotyping. Pre-S genes were also analyzed for
mutations. The basal core promoter (BCP) region was amplified and directly sequenced to analyze T1753V and
A1762T/G1764A mutations.
Results: The predominant HBV genotype among the Minangkabau HBV carriers (n=117) was C (72.6%) followed by
B (24.8%) and co-infection with B and C (2.6%). The prevalence of pre-S mutations, including both the pre-S
deletion and pre-S2 start codon mutation, was 41.0%, and the T1753V and A1762T/G1764A mutations were found
in 51.9% and 71.2% respectively. HBV/C1 was the predominant HBV subgenotype in the Minangkabau HBV carriers,
and was found in 66.2%, followed by B3, B7, C8, B2, B9, C2, and C10 (18.3%, 7.0%, 2.8%, 1.4%, 1.4%, 1.4%, and 1.4%
respectively). From samples that were found to be co-infected with HBV B and C, two samples were successfully
cloned and subgenotyped, including one with mixed subgenotypes of B3 and C1, and another one with mixed
subgenotypes of B7, C1, putative intergenotypic of B/A, and C/A. Furthermore, three samples from donors of
non-Minangkabau ethnicity from Padang were found to be infected with an intragenotypic recombination form,
including a putative recombinant of B8/B3 and B9/B7.
Conclusion: HBV/C with subgenotype C1 was the predominant HBV genotype among HBV carriers of Minangkabau
ethnicity. The prevalence of pre-S, A1762T/G1764A, and T1753V mutations was higher among the Minangkabau
compared to Indonesian HBV carriers in general.
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Hepatitis B virus is still one of the highest burden dis-
eases in the world. It is estimated that 30% of the world’s
population has had contact with or are carriers of the
hepatitis B virus (HBV) [1]. More than 75% of the 350
millions of HBV carriers are located in Western Pacific
and South East Asia region [2]. Although the incidence
of acute HBV infection has decreased in most countries
due to the implementation of vaccination programs,
HBV-related complications such as cirrhosis and hepato-
cellular carcinoma (HCC) are still increasing [1]. HBV is
responsible for chronic hepatitis progressing to cirrhosis
(10–20%), and as much as 20–30% of compensated cir-
rhosis will lead to hepatic decompensation, and 5–15%
of compensated cirrhosis will lead to HCC [3].
Classification of the HBV genotype was based on >8%
intergenotype and <4% intragenotype divergences [4,5].
Ten HBV genotypes (A-J) have been identified [6,7], and
each genotype can be further classified into subgenotypes
[4]. HBV genotypes have extremely uneven geographic
distributions, which can help in tracing its migration [5].
Genotypes B and C account for more than 90% of chronic
HBV infection in East Asia [8]. HBV genotype B is asso-
ciated with spontaneous HBeAg seroconversion at a
younger age, with less active liver disease, and a slower
rate of progression to cirrhosis compared with HBV geno-
type C [8,9]. Furthermore, HBV genotype C and specific
mutations of the basal core promoter (BCP) and precore
regions were associated with risk of HCC independent of
serum HBV DNA level [10].
Indonesia has moderate to high endemicity for HBV
infection, with a carrier rate of 5–20% in the general
population [11]. Genotype B is the predominant HBV
genotype in Indonesia, followed by genotypes C, D, and
A [12-14]. HBV/B is predominant in the western part of
Indonesia, whilst HBV/C is dominant on the eastern
part [13,14]. Mutations at the BCP region such as
A1762T/G1764A and T1753V were found in high preva-
lence (59.5% and 40.5%, respectively) and were asso-
ciated with severe liver disease [12]. In a more recent
study, the prevalence of pre-S mutation in Indonesian
population was also reported [15,16].
The Minangkabau ethnic group is one of the seven
major ethnic groups in Indonesia. They originated from
and still mainly reside in the West Sumatra province of
Sumatra Island [17]. Previous studies have shown that
HBV genotype C is the most prevalent among HBV car-
riers in this population, which is different from other
populations in Sumatra Island [12-14]. However, the
numbers of subjects in these studies were low. The aims
of the present study were to assess the HBV genotype
distribution as well as to determine the prevalence of
mutations in the pre-S and BCP regions of the HBV gen-
ome in HBV carriers of the Minangkabau ethnic group.We investigated those of Minangkabau ethnicity who
reside in Padang, the capital city of West Sumatra prov-
ince, and those in western Java. In addition, we com-
pared the genotype distribution among those of
Minangkabau with those of Javanese ethnicity, the
largest ethnic group in Indonesia.
Results
Demographic data of subjects in Padang population
A total of 189 HBsAg positive blood donors and liver
disease patients from the Padang region were included
in the study. The ethnicities of the 189 were Minangka-
bau (59.3%), half Minangkabau (only mother or father is
of Minangkabau ethnicity) (19.6%), Javanese (7.4%),
Bengkulu (2.1%), Nias (2.1%), Batak (1.6%), Sundanese
(1.6%), Jambi (1.1%), Kerinci (1.1%), Mentawai (1.1%),
and others (3.2%). From the 189 samples, 140 samples
were successfully genotyped and were grouped into the
Minangkabau and the non-Minangkabau ethnic group
(Table 1). The mean ± SD age of the 140 samples was
37.5 ± 11.6 years old and about 87.1% of them were
male. There was no significant difference in mean age
and gender between the two groups. Of the samples,
75.7% (106/140) were from blood donors and 24.3% (34/
140) were from patients with liver disease. HBV geno-
types found in Padang population were B (35.7%), C
(60.7%), and co-infection of B and C (3.6%). The preva-
lence of HBV/C in the Minangkabau ethnic group was
higher than in the non-Minangkabau ethnic group
(75.9% vs 38.6%, P<0.0003). Pre-S mutations in samples
from Padang were found in the form of pre-S deletion
and pre-S2 start codon mutations. From 140 samples
genotyped, 79 samples were successfully analyzed for
pre-S mutation. Thirty two of 79 samples (40.5%) had
pre-S mutations, including seven (8.9%) with both pre-S
deletion and mutation at the pre-S2 start codon, twelve
with pre-S deletion alone (15.2%) and thirteen (16.5%)
with pre-S2 start codon mutations only. Mutations at
the BCP region could only be analyzed in 58 of the 140
genotyped samples. The mutations A1762T/G1764A
and T1753V were found in high prevalence, 35/58
(60.3%) and 21/58 (36.2%) respectively. Mutations at
both the pre-S and BCP regions were found more
frequently in the Minangkabau than in the non-
Minangkabau ethnic groups. Furthermore, the preva-
lence of the T1753V mutation in the Minangkabau
ethnic group was significantly higher than in the non-
Minangkabau ethnic group (50.0% vs 19.2%, P=0.015)
(Table 1).
Demographic data of Minangkabau and Javanese ethnic
groups
A total of 117 plasma samples from HBV carriers of
Minangkabau ethnicity (83 from Padang and 34 from
Table 1 Demographic data and HBV variants mutant prevalence of HBV carrier in Padang population
Minangkabau, n=83 Non-Minangkabau, n=57 All, n=140 P
Male/Female, (%male) 72/11 (86.7) 50/7 (87.7) 122/18 (87.1) 0.866
Age ± SD 38.6±12.1 35.8±10.6 37.5±11.6 0.156
AC:CH:LC:HCC 55:8:17:3 51:0:5:1 106:8:22:4 0.010
Genotype, n(%)
B 17 (20.5) 33 (57.9) 50 (35.7) 2.76E-05
C 63 (75.9) 22 (38.6) 85 (60.7)
B/C 3 (3.6) 2 (3.5) 5 (3.6)
Pre-S mutation* 25 (50.0) 7 (24.1) 32 (40.5) 0.024
Pre-S deletion* 14 (28.0) 5 (17.2) 19 (24.1) 0.281
Pre-S2 start codon mut* 16 (32.0) 4 (13.8) 20 (25.3) 0.073
A1762T/G1764A** 22 (68.8) 13 (50.0) 35 (60.3) 0.147
T1753V** 16 (50.0) 5 (19.2) 21 (36.2) 0.015
AC Asymptomatic carrier, CH Chronic hepatitis, LC Liver cirrhosis, HCC Hepatocellular carcinoma.
*All=79, Minangkabau=50, Other=29.
**All=58, Minangkabau=32, Other=26.
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ples of Javanese HBV carriers (9 from Padang and 83
from western Java areas) as shown in Table 2. The mean
± SD age of the Minangkabau ethnic group was younger
than the Javanese (40.9 ± 13.0 vs 45.0 ± 12.1 years old,
P=0.020), while the ratios of male/female between the
two groups were not significantly different. Samples in
the Javanese ethnic group were mostly from liver disease
patients (91.3%), whilst almost half (47.0%) of samples
from Minangkabau ethnic group were from blood
donors (Table 2). The predominant genotype in the
Minangkabau ethnic group was C (73.5%) followed by B
(23.9%) and co-infection of B and C (2.6%). Conversely,
in the Javanese ethnic group the predominant genotypeTable 2 Demographic data and prevalence of HBV mutant va
ethnics
Minangkabau, n=117
Male/Female, (%male) 93/24 (79.5)






Pre-S mutation** 25 (41.0)
Pre-S deletion** 15 (24.6)
Pre-S2 start codon mut** 15 (24.6)
A1762T/G1764A*** 37 (71.2)
T1753V*** 27 (51.9)
AC Asymptomatic carrier, CH Chronic hepatitis, LC Liver cirrhosis, HCC Hepatocellula
**All=105, Minangkabau=61, Javanese=44.
***All=114, Minangkabau=52, Javanese=62.was B (88.0%) followed by C (10.9%), and co-infection of
B and C (1.1%) (Table 2).
The prevalence of HBV mutations between ethnic groups
showed different distribution patterns. For pre-S mutations
analysis 61 of 117 samples from the Minangkabau ethnic
group and 44 of 92 samples from the Javanese ethnic group
were successfully amplified. Pre-S mutations were found
more prevalent in the Javanese than in the Minangkabau
ethnic group (45.5% vs 41.0%). The pre-S2 start codon
mutation was more common than pre-S deletion (34.1% vs
4.5%, respectively) in the Javanese ethnic group, whilst both
type of mutations showed similar prevalence (16.4%) in the
Minangkabau ethnic group. Conversely with the pre-S














Siburian et al. Virology Journal 2013, 10:27 Page 4 of 11
http://www.virologyj.com/content/10/1/27the Minangkabau ethnic group than in the Javanese ethnic
group. For the BCP mutation analysis, 52 of 117 samples
from the Minangkabau ethnic group and 62 of 92 samples
from the Javanese ethnic group were successfully amplified.
The T1753V mutation was found in 51.9% and 27.4% of
the Minangkabau and Javanese ethnic groups (P=0.007),
whilst the A1762T/G1764A mutation was detected in
71.2% and 41.9% of the Minangkabau and Javanese ethnic
groups (P=0.002) (Table 2).
HBV subgenotype analysis
A total of 172 plasma samples (56 and 39 samples from the
Minangkabau and the non-Minangkabau ethnic groups in
Padang, with the addition of 15 and 62 samples with
Minangkabau and Javanese ethnicity from previous study in
western Java) were successfully subgenotyped. Phylogenetic
trees were constructed based on the pre-S sequence (n=129)
or the S gene (n=43) (Figures 1 and 2). In the Padang popu-
lation, the predominant subgenotype was C1 followed by
B3, B7, C10, B9, and C8 (Figure 3). The prevalence of HBV/
C1 in the Minangkabau group was significantly higher than
in the non-Minangkabau ethnic group, although HBV/C1
was predominant in both groups (73.2 vs 46.2, P=0.014). In
samples with co-infection of HBV/B and C, the subgenotype
could only be determined in two samples, both of the
Minangkabau ethnic group (11.101.057 and 11.101.072).
From sample 11.101.057, five clones of the S gene were suc-
cessfully retrieved, including four clones of HBV/B3 and
one clone of HBV/C1. From sample 11.101.072 eight clones
of the pre-S gene were retrieved, including five clones with
HBV/B7, one HBV/C1, one with putative intergenotypic re-
combinant of B/A and the last one with putative intergeno-
typic recombinant of C/A. Furthermore, three samples were
found to be infected with HBV intergenotypic recombinant
(11.101.118, 11.101.121, 11.101.135). All three were found in
the non-Minangkabau ethnic group. Samples 11.101.118
and 11.101.135 were found to be infected with an HBV pu-
tative recombinant of B8/B3, and 11.101.121 was found with
a putative recombinant of B9/B7.
Eighty three samples from HBV carriers of Minangkabau
ethnicity collected from the Padang population were com-
pared to 34 samples from HBV carriers of Minangkabau
ethnicity that resided in western Java. The HBV genotype
distribution patterns of the two groups were found to be
similar (Figure 3). Genotype C was the predominant
genotype in the Minangkabau ethnic group from both
Padang and western Java (75.9% vs 67.6%). Despite
the similar genotype distribution pattern, the subge-
notype distribution in the groups was different,
although the predominant subgenotype was the same
(HBV/C1). The subgenotypes found in the Minangka-
bau ethnic group in Padang were C1, B3, B7, B9, C8,
and C10 (73.2%, 19.6%, 1.8%, 1.8%, 1.8%, and 1.8% re-
spectively). Whilst the subgenotypes found in theMinangkabau ethnic group in western Java were C1,
B7, B3, B2, C2, and C8 (40.0%, 26.7%, 13.3%, 6.7%,
6.7%, and 6.7% respectively).
The HBV genotype and subgenotype distributions
were significantly different between Minangkabau and
Javanese HBV carriers (Figure 3). The subgenotypes
found in the Minangkabau ethnic group (from Padang
and western Java) were: C1, B3, B7, C8, B2, B9, C2, and
C10 (66.2%, 18.3%, 7.0%, 2.8%, 1.4%, 1.4%, 1.4% and
1.4% respectively), whereas four subgenotypes were
observed in the Javanese ethnic group including B3, B7,
C1, and B2 (50.7%, 34.8%, 13.0% and 1.5% respectively).
Discussion
Particular HBV genotypes are associated with the out-
come of chronic HBV infection and the response to anti-
viral therapies [8,18-20]. The prevalence of HBV
genotypes varies geographically, where genotypes B and
C account for more than 90% of chronic HBV infection
in East Asia [8]. Furthermore, HBV strains circulating in
an area can reflect the ethnic mix of its population
[13,14,21]. In the western part of Indonesia (Sumatra, Nias,
Mentawai, Kalimantan, Java and Lombok islands), HBV/B
was predominant [13]. Interestingly, in Minangkabau popu-
lation of West Sumatra the predominant HBV genotype is
HBV/C with subgenotype C1 [13,14]. HBV/C was found to
be predominant in the eastern part of Indonesia (Papua and
Papua-influenced populations of Moluccas) but of different
subgenotypes than those found in the western Indonesia
(C6 and C7) [13,14,22].
HBV/C was highly prevalent in the Minangkabau ethnic
group, whilst in non-Minangkabau ethnic groups HBV/B
was more prevalent. In the western Indonesian population,
the HBV/C was exclusively high in Minangkabau popula-
tion [13]. While our data supports the data from previous
studies, it also reveals the distinct HBV genotypes that
are conserved in those of Minangkabau ethnicity resid-
ing in Padang, as well as those of who live in western
Java (Figure 3). Minangkabau ethnic people have strong
traditions, and usually marry within their own group.
Studies of Minangkabau associations in different regions
indicate that they often develop out of pre-existing kin
or locality-based networks that promote social interac-
tions among their members [23]. The present data illus-
trate a conserved transmission route of HBV infection
which was most likely vertical, as it was obtained in
high prevalence areas where HBV infection usually
occurs perinatally or during infancy and early childhood
[18]. Thus, distinct HBV genotypes can be kept in soci-
eties living closely together even after migration over
long distances [24].
The HBV genotype C is independently associated with
a higher risk of HCC and associated with more rapid
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E, F, G, H, I
Genotype B
Figure 1 (See legend on next page.)
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Figure 1 The Neighbor-joining phylogenetic tree of the 436 nt pre-S sequence of 132 reported HBV strains from Padang and West
Java obtained in the present study (indicated with the accession numbers and sample ID) together with all reference sequences from
GenBank (indicated with the accession numbers, genotypes/subgenotypes, and country). HBV sequences typed in bold black are samples
from non-Minang ethnic in Padang and West Java, in bold green are samples from Minang ethnic in Padang, and in bold blue are samples from
Minang ethnic in western Java. The HBV genotypes/subgenotypes are indicated on the right of each respective cluster. Bootstrap values higher
than 70% are shown at major branches. The length of the horizontal bar indicates the number of nucleotide substitution per site.
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with chronic HBV infection followed up for a median of
7.7 years showed that the highest risk of developing
HCC was in persons infected with HBV genotype C2,
with the next highest being C1, followed by those
infected with genotype B (presumably Ba) [20]. Differ-
ences between the Asian genotypes B and C appears to
be influenced by the subgroup of genotype B, because in
Japan where the genotype B1 (Bj) is prevalent, no differ-
ences in the development of HCC between genotypes B
and C was observed [24]. The samples in this study were
mostly from blood donors, however the data demon-
strated a higher proportion of patients with liver disease
among those of Minangkabau ethnicity than in the non-
Minangkabau ethnic group (P=0.010) (Table 1).
Different HBV genotypes display distinct patterns of
mutations at the Pre-S region and at the EnhII, BCP, and
precore (EnhII/BCP/Precore) region in the HBV genome
[10]. The prevalence of pre-S mutants among different
HBV genotypes was significantly higher in patients with
genotypes B (25.0%) and C (24.5%) than the other geno-
types (P<0.05), but there was no significant difference
between genotypes B and C [25]. The A1762T/G1764A
mutation is more commonly found in patients with
genotype C than those with genotype B [8]. In Padang
population, the data demonstrated significantly higher
prevalence of pre-S mutant, T1753V, and A1762T/
G1764A in the Minangkabau compared to the non-
Minangkabau ethnic group. This was due to the higher
prevalence of HBV/C and liver disease patients who pro-
vided samples from the Minangkabau ethnic group. The
pre-S mutation was mostly found in HBV/C and in sam-
ples from liver disease patients of the Padang population
(data not shown).
In contrast to the results in Padang population, pre-S
mutations in samples from the Minangkabau ethnic
group (from Padang and western Java) were less preva-
lent compared to those from the Javanese ethnic group,
although this difference was not statistically significant.
In particular, pre-S2 start codon mutation was more
common in samples from the Javanese ethnic group
than in those from the Minangkabau ethnic group
(Table 2). This is most likely due to the higher percent-
age of liver disease patients in the Javanese ethnic group.
The frequencies of mutations at the pre-S2 promoters
were significantly higher in the patients with HCC thanin the patients without HCC (pre-S2 promoter mutation:
15.3% vs 8.9%, P=0.032) [10]. Furthermore, pre-S2 start
codon mutation was associated with advanced liver dis-
ease and was the more common type of pre-S mutation
in Indonesian patients regardless of the HBV genotype
[15,16].
The prevalence of the A1762T/G1764A mutation was
significantly higher in the Minangkabau compared to the
Javanese ethnic group. This result demonstrated the high
prevalence of the A1762T/G1764A mutation in HBV/C
regardless of the stage of infection. A previous meta-
analysis study, evaluating 43 studies with a total of
11582 HBV-infected participants, found that the fre-
quency of C1653T, T1753V, and TA mutations increased
successively from asymptomatic carrier to cirrhosis, and
were independent factors associated with HCC. The
C1653T mutation in HBV subgenotype C2 and T1753V
and A1762T/G1764A in HBV subgenotypes C1 and C2
were statistically significantly associated with an
increased risk of HCC. Furthermore, the study men-
tioned that pre-S mutations C1653T, T1753V, and
A1762T/G1764A accumulated during the progression of
chronic HBV infection from the asymptomatic carrier
state to HCC (Ptrend<0.001 for each mutation) [10].
Random errors and variations in the HBV genome that
occur over long periods while immune selection pres-
sures operate at the population level have led to the
emergence of distinct genotypes and subgenotypes in
specific geo-ethnic populations. Since these variants are
transmission competent, they can stably circulate within
the given geo-ethnic population [26]. HBV genotypes
may add additional support to anthropological data on
ancient migration events [24]. The distribution of HBV
genotypes/subgenotypes in the Indonesian archipelago is
related to the ethnic origin of its populations and sug-
gests that the HBV distribution is associated with the
ancient migratory events in the peopling of the archipe-
lago [13].
HBV/C1 was commonly found in Southeast Asia (the
western part of Indonesia, Malaysia, Thailand, Vietnam
and Bangladesh) and Southern China [12,13,20,21,27].
The Malay populations in the western (Melayu Minang-
kabau) and southern parts (Melayu Jawa and Melayu
Bugis) of the Peninsular Malaysia were believed to have
had more historical and cultural links with the popula-






































































































































































Figure 2 (See legend on next page.)
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Figure 2 The Neighbor-joining phylogenetic tree of the 323 nt S sequence of 45 reported HBV strains from Padang and West Java
obtained in the present study (indicated with the accession numbers and sample ID) together with all reference sequences from
GenBank (indicated with the accession numbers, genotypes/subgenotypes, and country). HBV sequences typed in bold black are samples
from non-Minang ethnic in Padang and West Java, in bold green are samples from Minang ethnic in Padang, and in bold blue are samples from
Minang ethnic in western Java. HBV genotypes/subgenotypes are indicated on the right of each respective cluster. Bootstrap values higher than
70% are shown at major branches. The length of the horizontal bar indicates the number of nucleotide substitution per site.
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measure of Fst (a method to show population genetic
structure by partitioning genetic variance within popula-
tions relative to between populations), demonstrated
that the Malay Minangkabau are grouped with the
Indonesian Melayu. This topology may reflect the migra-
tions of Malay Minangkabau to Malay Peninsula from
Sumatra, the geographic origins of Indonesian Melayu
[28]. Genotypes B and C were equally frequent in ethnic
Malays, where most genotype C strains were subgeno-
type C1 [21].
The multiethnic origin of the populations is reflected
in the HBV genotype distribution in different parts of
the country [26]. The successfully subgenotyped samples
from the non-Minangkabau ethnic group classified in
this study was comprised of half Minangkabau descen-
dants, Javanese and Sundanese (originating from Java is-
land), and ethnic groups from other parts of Sumatra
island (41.0%, 23.1%, 35.9%, respectively). Most of the
HBV/C1 samples from the non-Minangkabau ethnic
group belong to the half Minangkabau (72.2%) and
Bengkulu people (11.1%). Bengkulu is a province near
West Sumatera province. On the other hand, most of
the HBV/B3 and HBV/B7 were found in the Javanese
(45.5% and 66.7%, respectively). Three samples with
intragenotypic recombinant HBV were detected in the
non-Minangkabau ethnic group, two with B8/B3 and
one with B9/B7. The samples that contained B8/B3 re-
combinant were detected in blood donors originated
from Mentawai (11.101.135), an island near West Suma-
tra province, and from Simeuleu (11.101.118), an island
near Aceh province, whilst the B9/B7 genotype was
detected in a blood donor sample that originated from
Bengkulu (11.101.121). Co-infection with more than one
HBV genotype may also be a more common occurrence
than what was previously thought. Among the Asian
patients from Vietnam, significantly higher associations
were found between mixed genotype infections and
acute hepatitis B, liver cirrhosis, and HCC although the
specific combination was impossible to identify due to
the different mixtures reported [20]. There were five
samples from Padang population (1.9%) that were found
to be co-infected with HBV/B and HBV/C, and all five
were from blood donors. Two out of five were
successfully cloned for subgenotyping (11.101.057 and
11.101.072). From sample 11.101.057, the S region wasamplified and cloned. Five clones were obtained, four
clones were HBV/B3 and one was HBV/C1. Whilst from
sample 11.101.072, the pre-S region was successfully
amplified and cloned. Interestingly, a mixture of subge-
notypes variants was found. From eight clones obtained,
five clones were HBV/B7, one clone was a putative inter-
genotypic recombinant strain of B/A, one clone was
HBV/C1, and one clone was a putative intergenotypic
recombinant strain of C/A.
In conclusion, the prevalence of HBV in blood
donors in Padang was relatively low. The predominant
HBV genotype and subgenotype in HBV carriers of
Minangkabau ethnic group is HBV/C with subgenotype
C1, which is different from the Indonesian population
in general. The transmission route of HBV infection is
most likely vertical, which allowed circulation of a
conserved HBV genotype within the Minangkabau eth-
nic population. The prevalence of pre-S, A1762T/
G1764A, and T1753V mutations were higher among
HBV carriers of Minangkabau ethnicity. However, the
association of the high prevalence of HBV/C1 and mu-
tant variants with increased risk of advance liver dis-




HBsAg screening tests were done for plasma samples
from blood donors at the Padang Red Cross Unit from
June 2010-July 2011. From 27,557 blood donor samples,
147 samples (0.53%) were found positive for HBsAg. In
addition to the 147 HBsAg-positive samples from blood
donors, 42 samples collected from HBV-related liver dis-
ease patients at the M. Djamil Hospital Padang were also
included and made a total of 189 samples analyzed for
genotyping. The liver disease samples comprised of 16
samples from patients with chronic hepatitis (CH), 22
samples from those with liver cirrhosis (LC), and 4 sam-
ples from those with HCC. Chronic hepatitis patients
were defined as those positive for HBsAg for more than
6 months, and have more than twice the normal ALT
level. Liver cirrhosis was diagnosed by liver function
tests and ultrasonography, whilst the diagnosis of HCC
was either on the basis of ultrasonography as well as an
elevated serum α-fetoprotein (AFP) level (≥ 200 ng ml-1),
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Figure 3 Distribution of HBV genotypes/subgenotypes obtained in this study from Padang and western Java (Jakarta and Tangerang)
in comparison with HBV genotypes/subgenotypes from Papua, previously reported by Lusida et al. [22].
Siburian et al. Virology Journal 2013, 10:27 Page 9 of 11
http://www.virologyj.com/content/10/1/27which the AFP level was low. From 189 samples, 140
samples were successfully genotyped. The 140 samples
were grouped into Minangkabau ethnicity and other eth-
nicity. HBsAg test for liver disease samples were per-
formed using a commercially available ELISA kit
(Abbott Laboratories, Chicago, IL), whilst HBsAg test
for samples from blood donors were done by ELISA kit
HepanostikaW HBsAg Ultra (BioMérieux SA, Marcy
l'Etoile, France). Blood samples were collected from sub-
jects at the time of their clinical evaluation or blood do-
nation, separated into plasma and stored at −70°C until
use. The study was approved by the Committee on
Health Research Ethics of the Mochtar Riady Institute
for Nanotechnology and informed consent was obtained
from each subject.
For comparison purpose, we included 117 HBsAg
positive samples from our previous study that were of
Minangkabau or Javanese ethnics collected from hospi-
tals in western Java area (34 and 83 samples, respect-
ively). These samples were later combined with the
samples from Padang to further compared HBV geno-
type and subgenotype distribution between Minangka-
bau and Javanese ethnic (Figure 3).HBV genotyping
HBV DNA was extracted from 200 μl plasma using the
QIAamp DNA blood mini kit (Qiagen, Hilden, Germany)according to the manufacturer’s instructions, and 80 μl
of eluted DNA was stored at −70°C until use. HBV geno-
typing was performed by Polymerase Chain Reaction
using genotype specific primers as described by Naito
et al. [29]. The PCR products were run in agarose 2% and
visualized under UV light.
HBV pre-S and BCP mutations analysis
Pre-S region was amplified by PCR using PCR Core Sys-
tem (Promega, Madison, WI, USA) and primers as pre-
viously described [15]. The PCR products were purified
with WizardW SV Gel and PCR Clean-Up System
(Promega, Madison, WI, USA), directly sequenced
employing an ABI 3130xl Genetic Analyzer (Applied
Biosystems, Inc., Foster City, CA, USA) with the Big Dye
Terminator V3.1 Cycle Sequencing kit (Applied Biosys-
tems, Inc.) using appropriate primers. Pre-S amino acid
sequences were aligned and compared between each
group to detect the mutations. BCP region was amplified
as previously described [12]. Retrieved sequenced were
aligned with reference sequences from GenBank and
analyzed for mutation.
Phylogenetic analysis
The HBV subgenotype was determined by phylogenetic
analysis of the pre-S (pre-S1/S2) or HBsAg (S)
sequences. The Pre-S or S region was amplified with
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sequences of all previously described HBV genotypes
and subgenotypes were retrieved from GenBank data-
base together with all samples obtained in this study to
construct phylogenetic trees based on partial pre-S or S
region by the neighbor-joining method [31] using the
maximum composite likelihood method to calculate
evolutionary distances [32]. Bootstrap resampling was
performed 1,000 times. All phylogenetic analyses were
carried out using the MEGA5 software [33]. The geno-
types and subgenotypes of the samples were determined
based on their phylogenetic co-clustering with the refer-
ence sequences. The possibility of recombination in the
pre-S or S sequences were assessed in samples showing
ambiguous phylogenetic clustering using web-based
genotyping resource (Genotyping tool, NCBI [http://
www.ncbi.nlm.nih.gov/projects/genotyping/formpage.
cgi]) and further confirmed using SimPlot v3.2 software.
HBV pre-S and S gene sequences were deposited in
GenBank under accession number JQ029166-JQ029269;
JQ428829-JQ429078 and JX196538-JX196592. BCP
sequences were deposited in GenBank under accession
number JX196400-JX196537.
Statistical analysis
All statistical analyses were performed using SPSS 17.0
software for Windows (SPSS Inc., Chicago, IL, USA).
Statistical significances were determined using Fisher’s
exact test, chi-square test, and t-test analysis whenever
appropriate. P<0.05 was considered significant.
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